WP
TENX icon

Woodline Partners’s Tenax Therapeutics TENX Stock Holding History

Woodline Partners’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.18M Buy
323,911
+180,430
+126% +$2.44M 0.02% 657
2025
Q4 		$1.75M Buy
143,481
+55,270
+63% +$481K 0.01% 785
2025
Q3 		$671K Buy
+88,211
New +$539K ﹤0.01% 823

Other funds holding TENX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Woodline Partners's TENX Position: Q1 2026 in Review

Woodline Partners increased its Tenax Therapeutics (TENX) stake by 126% in Q1 2026, buying an estimated $2.44M and bringing the position to 323,911 shares worth $5.18M. The position accounts for 0.02% of the portfolio, ranked #657.

Woodline Partners first reported a position in TENX in Q3 2025 and has held it in 3 quarters since. 80 funds tracked by Wall St. Rank hold TENX as of Q1 2026.

  • Woodline Partners held 323,911 shares of Tenax Therapeutics worth $5.18M as of Q1 2026.
  • Woodline Partners bought 180,430 Tenax Therapeutics shares in Q1 2026, an estimated $2.44M.
  • Tenax Therapeutics made up 0.02% of Woodline Partners's portfolio in Q1 2026, its #657 holding.
  • Woodline Partners first reported a position in Tenax Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • 80 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q1 2026.

Based on Woodline Partners's 13F filing for Q1 2026, filed 15 May 2026.